Registration now open for BOS Events 2025!

Dates for BOS Events 2025 are 11th and 12th June for BOS Basel 2025, and 25th and 26th November for BOS Manchester 2025. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2025)

PHT Pharmaceutical AG
PHT International is a US-headquarterted CRO, CDMO and fine chemicals trading / sourcing services organization with manufacturing sites and labs in China.

CRO services include

Medicinal chemistry

Analog Synthesis
Heterocycles
Discovery and focused libraries
Scaffold Hopping
Synthetic route...
View profile

Featured Speaker (BOS Basel 2025)

A Novel Series of Ivosidenib-Polymer Cocrystals

Dr Adam Patterson, Senior Scientist I, Veranova

ABSTRACT: Novel series of Ivosidenib-Polymer cocrystals - Oral presentation by Adam R. Patterson, Veranova (Cambridge, UK)
Pharmaceutical salts are a ubiquitous front-line approach to improve the inherent low aqueous solubility of increasingly complex small molecules where an ionisable group is present. Within pharmaceuticals, cocrystals have been increasingly investigated and found wider regulatory acceptance in the prior two decades and their formation can provide a viable alternative to improve aqueous solubility and tune solid form properties of non-ionisable active molecules. We argue that cocrystallisation... Click here to Read More